Glycogen Storage Disease IIIA

Known as: GSD IIIA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2013
012319972013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Glycogenosis type III (GSD III) is an autosomal recessive disorder due to amylo-1,6-glucosidase deficiency. This disease causes… (More)
Is this relevant?
2013
2013
Myopathic symptoms in Glycogen Storage Disease Type IIIa (GSD IIIa) are generally ascribed to the muscle wasting that these… (More)
Is this relevant?
2013
2013
We investigated the feasibility of using recombinant human acid-α glucosidase (rhGAA, Alglucosidase alfa), an FDA approved… (More)
  • figure 1
Is this relevant?
2012
2012
In glycogen storage disease type III (GSD III), deficiency of the debranching enzyme causes storage of an intermediate glycogen… (More)
  • table 1
  • figure 1
Is this relevant?
2012
2012
PURPOSE To investigate the distribution and clinical impact of glycogen accumulation on heart structure and function in… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2011
2011
Glycogen storage diseases (GSDs) comprise a large, heterogeneous group of disorders characterized by abnormal glycogen deposition… (More)
  • table 1
Is this relevant?
2008
2008
Glycogen storage disease type III (GSD III) is a very rare disorder caused by a deficiency in the activities of glycogen… (More)
Is this relevant?
2004
2004
Glycogen storage disease type III (GSD III) is an inborn error of glycogen metabolism caused by a deficiency of glycogen… (More)
Is this relevant?
2002
2002
Hyperphenylalaninemia result from a block in the conversion of phenylalanine into tyrosine due to a defect in either the enzyme… (More)
Is this relevant?
1997
1997
Subjects with glycogen storage disease type III (GSD III, debrancher enzyme deÐciency ; McKusick 232400) are at risk of… (More)
Is this relevant?